Hims & Hers rebounds with key partnerships and launches, achieving 111% YoY revenue growth. Learn more about HIMS stock here.

Hims & Hers Health shows impressive operating leverage and a scalable business model, with massive growth potential from new ...

Short interest in Hims & Hers Health Inc rose to a record high, even as shares surged following strong first-quarter results.

President Trump signed the executive order shortly before 11 a.m. after a press conference in which he and top officials ...

An ad for compounded versions of weight-loss drug semaglutide by telehealth company Hims & Hers has attracted ... Nordisk's blockbuster weight-loss drug Wegovy, which achieved sales of around ...